Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna M Milan

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Genes & Diseases|June 10, 2022
Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolismBrendan P Norman, Andrew S Davison, Juliette H Hughes, et al.
Journal of Inherited Metabolic Disease|February 22, 2020
Nitisinone causes acquired tyrosinosis in alkaptonuriaMilad Khedr, Maggie S Cooper, Andrew T Hughes, et al.
Journal of Inherited Metabolic Disease|October 15, 2019
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuriaLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Annals of the Rheumatic Diseases|December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatmentLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
The Lancet. Diabetes & Endocrinology|August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trialLakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Genes & Diseases|June 10, 2022
Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolismBrendan P Norman, Andrew S Davison, Juliette H Hughes, et al.
Journal of Inherited Metabolic Disease|February 22, 2020
Nitisinone causes acquired tyrosinosis in alkaptonuriaMilad Khedr, Maggie S Cooper, Andrew T Hughes, et al.
Journal of Inherited Metabolic Disease|October 15, 2019
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuriaLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Annals of the Rheumatic Diseases|December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatmentLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
The Lancet. Diabetes & Endocrinology|August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trialLakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Pageof 4